Is Jentadueto a Controlled Substance? No

No. Jentadueto (linagliptin and metformin) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and linagliptin and metformin is not on the DEA controlled substances list.

Run it in Rivvi

Which 2027 plans near you dropped or restricted Jentadueto?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Jentadueto
Source	What it lists
FDA NDC directory	3 prescription listings from 1 labelers, none with a DEA schedule
DEA controlled substances list	linagliptin and metformin is not on the list

Jentadueto NDC listings

NDC listings for Jentadueto
NDC	Product	Form	Strength	Labeler	DEA schedule
0597-0148	Jentadueto	tablet, film coated	2.5 mg/1; 1000 mg/1	Boehringer Ingelheim Pharmaceuticals, Inc.	None
0597-0146	Jentadueto	tablet, film coated	2.5 mg/1; 500 mg/1	Boehringer Ingelheim Pharmaceuticals, Inc.	None
0597-0147	Jentadueto	tablet, film coated	2.5 mg/1; 850 mg/1	Boehringer Ingelheim Pharmaceuticals, Inc.	None

Questions

Is Jentadueto a controlled substance?

No. Jentadueto (linagliptin and metformin) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and linagliptin and metformin is not on the DEA controlled substances list.

Is Jentadueto a narcotic?

No. Jentadueto (linagliptin and metformin) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Biguanide and Dipeptidyl Peptidase 4 Inhibitor.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.